US Stock MarketDetailed Quotes

PRAX Praxis Precision Medicines

Watchlist
  • 75.350
  • +3.480+4.84%
Close Nov 7 16:00 ET
  • 75.350
  • 0.0000.00%
Post 16:20 ET
1.40BMarket Cap-8217P/E (TTM)

Praxis Precision Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-35.47%302K
-54.29%357K
-36.90%431K
2.45M
515K
468K
781K
683K
0
0
Operating revenue
-35.47%302K
-54.29%357K
-36.90%431K
--2.45M
--515K
--468K
--781K
--683K
--0
--0
Cost of revenue
Gross profit
Operating expense
119.89%57.14M
5.89%37.85M
9.14%42.32M
-40.08%128.82M
-31.68%28.32M
-41.33%25.98M
-40.82%35.74M
-43.68%38.77M
28.48%214.99M
-29.33%41.45M
Selling and administrative expenses
74.87%15.26M
4.52%10.59M
15.55%15.33M
-29.85%42.05M
-24.31%9.93M
-37.02%8.72M
-39.63%10.13M
-18.07%13.27M
27.34%59.95M
-13.35%13.12M
-General and administrative expense
74.87%15.26M
4.52%10.59M
15.55%15.33M
-29.85%42.05M
-24.31%9.93M
-37.02%8.72M
-39.63%10.13M
-18.07%13.27M
27.34%59.95M
-13.35%13.12M
Research and development costs
142.65%41.88M
6.43%27.26M
5.80%26.98M
-44.04%86.77M
-35.09%18.39M
-43.30%17.26M
-41.28%25.61M
-51.56%25.5M
28.92%155.04M
-34.89%28.33M
Operating profit
-122.74%-56.84M
-7.23%-37.49M
-9.96%-41.89M
41.22%-126.37M
32.92%-27.81M
42.39%-25.52M
42.11%-34.96M
44.67%-38.09M
-28.48%-214.99M
29.33%-41.45M
Net non-operating interest income expense
Other net income (expense)
457.13%4.93M
642.44%4.81M
266.82%2.33M
223.51%3.1M
231.43%928K
156.23%884K
224.00%648K
381.82%636K
253.14%957K
300.00%280K
Other non- operating income (expenses)
457.13%4.93M
642.44%4.81M
266.82%2.33M
223.51%3.1M
231.43%928K
156.23%884K
224.00%648K
381.82%636K
253.14%957K
300.00%280K
Income before tax
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
-28.11%-214.03M
29.72%-41.17M
Income tax
Net income
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
-28.11%-214.03M
29.72%-41.17M
Net income continuous Operations
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
-28.11%-214.03M
29.72%-41.17M
Minority interest income
Net income attributable to the parent company
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
-28.11%-214.03M
29.72%-41.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
-28.11%-214.03M
29.72%-41.17M
Basic earnings per share
-1.10%-2.75
76.42%-1.74
73.16%-2.84
73.17%-18.69
84.98%-1.96
81.11%-2.72
62.73%-7.38
53.29%-10.58
-17.85%-69.65
33.08%-13.05
Diluted earnings per share
-1.10%-2.75
76.42%-1.74
73.16%-2.84
73.17%-18.69
84.98%-1.96
81.11%-2.72
62.73%-7.38
53.29%-10.58
-17.85%-69.65
33.08%-13.05
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -35.47%302K-54.29%357K-36.90%431K2.45M515K468K781K683K00
Operating revenue -35.47%302K-54.29%357K-36.90%431K--2.45M--515K--468K--781K--683K--0--0
Cost of revenue
Gross profit
Operating expense 119.89%57.14M5.89%37.85M9.14%42.32M-40.08%128.82M-31.68%28.32M-41.33%25.98M-40.82%35.74M-43.68%38.77M28.48%214.99M-29.33%41.45M
Selling and administrative expenses 74.87%15.26M4.52%10.59M15.55%15.33M-29.85%42.05M-24.31%9.93M-37.02%8.72M-39.63%10.13M-18.07%13.27M27.34%59.95M-13.35%13.12M
-General and administrative expense 74.87%15.26M4.52%10.59M15.55%15.33M-29.85%42.05M-24.31%9.93M-37.02%8.72M-39.63%10.13M-18.07%13.27M27.34%59.95M-13.35%13.12M
Research and development costs 142.65%41.88M6.43%27.26M5.80%26.98M-44.04%86.77M-35.09%18.39M-43.30%17.26M-41.28%25.61M-51.56%25.5M28.92%155.04M-34.89%28.33M
Operating profit -122.74%-56.84M-7.23%-37.49M-9.96%-41.89M41.22%-126.37M32.92%-27.81M42.39%-25.52M42.11%-34.96M44.67%-38.09M-28.48%-214.99M29.33%-41.45M
Net non-operating interest income expense
Other net income (expense) 457.13%4.93M642.44%4.81M266.82%2.33M223.51%3.1M231.43%928K156.23%884K224.00%648K381.82%636K253.14%957K300.00%280K
Other non- operating income (expenses) 457.13%4.93M642.44%4.81M266.82%2.33M223.51%3.1M231.43%928K156.23%884K224.00%648K381.82%636K253.14%957K300.00%280K
Income before tax -110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M-28.11%-214.03M29.72%-41.17M
Income tax
Net income -110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M-28.11%-214.03M29.72%-41.17M
Net income continuous Operations -110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M-28.11%-214.03M29.72%-41.17M
Minority interest income
Net income attributable to the parent company -110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M-28.11%-214.03M29.72%-41.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M-28.11%-214.03M29.72%-41.17M
Basic earnings per share -1.10%-2.7576.42%-1.7473.16%-2.8473.17%-18.6984.98%-1.9681.11%-2.7262.73%-7.3853.29%-10.58-17.85%-69.6533.08%-13.05
Diluted earnings per share -1.10%-2.7576.42%-1.7473.16%-2.8473.17%-18.6984.98%-1.9681.11%-2.7262.73%-7.3853.29%-10.58-17.85%-69.6533.08%-13.05
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data